New Consortium: Consortium on Modeling Autoimmune Diabetes

Five new awards were announced for the newly created HIRN Modeling Autoimmune Diabetes (CMAD) (RFA-DK-23-004)

• Models to Study the Synergy between Autoimmunity and Metabolism in T1D (UG3 DK14192)
  Mike Brehm*, PhD, University of Massachusetts Medical School
  George Daley, PhD, Harvard Medical School
  Accalia Fu, PhD, University of Massachusetts Medical School
  Dave Harlan, PhD, University of Massachusetts Medical School
  Lenny Shultz, PhD, The Jackson Laboratory 
  Peng Yi, PhD, Joslin Diabetes Center

• Advanced Pancreatic-immune Organoid Models of Type 1 Diabetes Subtypes and Therapeutic Responses (UG3 DK142189)
  Kevan Herold*, PhD, Yale School of Medicine
  Paula Alonso-Guallart, DVM, PhD, New York Stem Cell Foundation
  Rick Monsma, PhD, New York Stem Cell Foundation
  Mark Mamula, PhD, Yale School of Medicine
  Richard Kibbey, MD, PhD, Yale School of Medicine

• Understanding Thymic Epithelial and Hematopoietic Stem Cell-intrinsic Immune Abnormalities Driving T1D in Optimized HIS Mouse Models (UG3 DK142184)
  Megan Sykes*, PhD, Columbia University
  Remi Creusot, PhD, Columbia University
  Holger Russ, PhD, University of Florida

• Studying the Mechanism of Initiation and Progression of Beta Cell Death in T1D (UG3 DK142188)
  Luc Teyton*, PhD, Scripps Research
  Chris Hughes, PhD, University of California, Irvine
  Jeff Millman, PhD, Washington University School of Medicine in St. Louis

• Stem Cell-based Modeling of Type 1 Diabetes to Accelerate Translation of Therapies (UG3 DK142187)
  Audrey Parent*, PhD, University of California, San Francisco
  Kyle Loh, PhD, Stanford University
  Qizhi Tang, PhD, University of California, San Francisco

* Denotes Contact PI